IPAC-RS

Publications & Presentations

Showing 190 results

View

Recommended Baseline Requirements for Materials used in Orally Inhaled and Nasal Drug Products (OINDP)

February 9, 2017
Related Working Group(s): OINDP Materials
(published)

View

A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals

Terrence P. Tougas, Adrian P. Goodey, Gareth Hardwell, Jolyon Mitchell, Svetlana Lyapustina April 11, 2016
Related Working Group(s): Cascade Impaction (CI)
AAPS PharmSciTech, pp. 1-11
(published)

View

IPAC-RS February 2016 Newsletter

is available at: IPAC-RS. February 2016
(published)

View

IPAC-RS December 2015 Newsletter

is available at: IPAC-RS. December 2015
(published)

View

Baseline Requirements for Materials used in Orally Inhaled and Nasal Drug Products (OINDP): An Update to the 2011 Document

Thomas N. Feinberg, Ph.D. 5/14/2015
Related Working Group(s): OINDP Materials
Smithers Rapra Extractables & Leachables USA Conference
(published)

View

Presentations and Q&A from AIM and EDA of Aerodynamic Particle Size Data from Orally Inhaled Products Workshop at RDD Europe 2015

is available at: IPAC-RS. May 6, 2015
Related Working Group(s): Cascade Impaction (CI)
RDD Europe 2015, Nice, France
(published)

View

The Science of Quality for Patient Benefit

is available at: IPAC-RS. Helen Strickland, GlaxoSmithKline January 28, 2015
Related Working Group(s): Delivered Dose Uniformity (DDU)
IFPAC Conference, Arlington, VA
(published)

See member benefits

Become an IPAC-RS member today Participation in IPAC-RS affords a variety of benefits including opportunities to shape the scientific and regulatory environment and tools to stay informed.

Sign Up

IPAC-RS members can sign up to receive our monthly update on IPAC-RS and regulatory developments.